Cargando…

Alternative Donor Transplantation for Acute Myeloid Leukemia

Allogeneic hematopoietic cell transplantation (allo-HCT) is a potentially curative therapy for adult patients with acute myeloid leukemia (AML), but its use for consolidation therapy after first remission with induction chemotherapy used to be limited to younger patients and those with suitable dono...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bejanyan, Nelli, Haddad, Housam, Brunstein, Claudio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4484998/ https://www.ncbi.nlm.nih.gov/pubmed/26239557 http://dx.doi.org/10.3390/jcm4061240

Ejemplares similares

Immune Reconstitution after Haploidentical Donor and Umbilical Cord Blood Allogeneic Hematopoietic Cell Transplantation
por: Elmariah, Hany, et al.
Publicado: (2021)

MDS disease characteristics, not donor source, predict hematopoietic stem cell transplant outcomes
por: Pourhassan, H, et al.
Publicado: (2016)

Prognostic factors for clinical outcomes of patients with central nervous system leukemia
por: Bharucha, Jinai, et al.
Publicado: (2020)

Alternative donor transplantation for acute myeloid leukemia in patients aged ≥50 years: young HLA-matched unrelated or haploidentical donor?
por: Perales, Miguel-Angel, et al.
Publicado: (2020)

Azacitidine and donor lymphocytes infusions in acute myeloid leukemia and myelodysplastic syndrome relapsed after allogeneic hematopoietic stem cell transplantation from alternative donors
por: Liberatore, Carmine, et al.
Publicado: (2022)

Donor-derived acute promyelocytic leukemia presenting as myeloid sarcoma in a transplanted kidney
por: Wong, Risa L., et al.
Publicado: (2020)

Donor-Derived Leukemia in a Recipient of Double-Unit Cord Blood Transplantation for Acute Myeloid Leukemia: A Case Study and Literature Review
por: Plesa, Adriana, et al.
Publicado: (2022)

Haploidentical transplant with posttransplant cyclophosphamide vs matched related and unrelated donor transplant in acute myeloid leukemia and myelodysplastic neoplasm
por: Rieger, Max J., et al.
Publicado: (2023)

ALTERNATIVE DONORS EXTEND TRANSPLANTATION FOR PATIENTS WITH LYMPHOMA WHO LACK AN HLA MATCHED DONOR
por: Bachanova, Veronika, et al.
Publicado: (2014)

Nonengraftment donor lymphocyte infusions for refractory acute myeloid leukemia
por: Reagan, J L, et al.
Publicado: (2015)

Alternate Donor Transplantation
por: Hwang, William YK, et al.
Publicado: (2022)

Autologous Stem Cell Transplantation in elderly Acute Myeloid Leukemia
por: Ossenkoppele, Gert J, et al.
Publicado: (2013)

Allogeneic Hematopoietic Cell Transplantation for Older Adults with Acute Myeloid Leukemia
por: Lipof, Jodi J., et al.
Publicado: (2018)

History and Development of Autologous Stem Cell Transplantation for Acute Myeloid Leukemia
por: Gorin, Norbert Claude
Publicado: (2021)

Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemia
por: Dholaria, Bhagirathbhai, et al.
Publicado: (2021)

Ruxolitinib early administration reduces acute GVHD after alternative donor hematopoietic stem cell transplantation in acute leukemia
por: Zhang, Binglei, et al.
Publicado: (2021)

Donor‐transmitted extramedullary acute myeloid leukaemia after living donor kidney transplantation
por: Ghandili, Susanne, et al.
Publicado: (2022)

Comparison of matched sibling donors versus unrelated donors in allogeneic stem cell transplantation for primary refractory acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT
por: Brissot, Eolia, et al.
Publicado: (2017)

Post-Transplant Cyclophosphamide after Matched Sibling and Unrelated Donor Hematopoietic Stem Cell Transplantation in Pediatric Patients with Acute Myeloid Leukemia
por: Sheikh, Irtiza N., et al.
Publicado: (2022)

Pharmacologic Strategies for Post-Transplant Maintenance in Acute Myeloid Leukemia: It Is Time to Consider!
por: Abou Dalle, Iman, et al.
Publicado: (2022)

Acute Myeloid Leukemia: Is It T Time?
por: Khoud, Meriem Ben, et al.
Publicado: (2021)

Thiotepa-busulfan-fludarabine compared to busulfan-fludarabine for sibling and unrelated donor transplant in acute myeloid leukemia in first remission
por: Saraceni, Francesco, et al.
Publicado: (2017)

Donor-derived diffuse large B-cell lymphoma after haploidentical stem cell transplantation for acute myeloid leukemia
por: Kawashiri, Anna, et al.
Publicado: (2022)

Allogeneic stem cell transplantation in acute myeloid leukemia
por: Ali, Natasha, et al.
Publicado: (2012)

Prognostic impact of pre-transplant chromosomal aberrations in peripheral blood of patients undergoing unrelated donor hematopoietic cell transplant for acute myeloid leukemia
por: Wang, Youjin, et al.
Publicado: (2021)

Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia: An Overview of Systematic Reviews
por: He, Peijie, et al.
Publicado: (2022)

Is There Still a Role for Autologous Stem Cell Transplantation for the Treatment of Acute Myeloid Leukemia?
por: Ferrara, Felicetto, et al.
Publicado: (2019)

Maintenance therapy in acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation
por: Xuan, Li, et al.
Publicado: (2021)

Effective Immunosurveillance After Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia
por: Kunadt, Desiree, et al.
Publicado: (2021)

Allogeneic stem cell transplantation in the treatment of acute myeloid leukemia: An overview of obstacles and opportunities
por: Chen, Yong-Feng, et al.
Publicado: (2023)

Classification of acute myeloid leukemia
por: Hwang, Sang Mee
Publicado: (2020)

Azacitidine, lenalidomide and donor lymphocyte infusions for relapse of myelodysplastic syndrome, acute myeloid leukemia and chronic myelomonocytic leukemia after allogeneic transplant: the Azalena-Trial
por: Schroeder, Thomas, et al.
Publicado: (2023)

Therapeutic Targeting of Acute Myeloid Leukemia by Gemtuzumab Ozogamicin
por: Gottardi, Michele, et al.
Publicado: (2021)

Comparison of Matched Unrelated and Matched Related Donor Myeloablative Hematopoietic Cell Transplantation for Adults with Acute Myeloid Leukemia in First Remission
por: Walter, Roland B., et al.
Publicado: (2010)

Identification of survival-related alternative splicing signatures in acute myeloid leukemia
por: Zhang, Biyu, et al.
Publicado: (2021)

Tipifarnib in the treatment of acute myeloid leukemia
por: Thomas, Xavier, et al.
Publicado: (2007)

Differentiation Therapy of Acute Myeloid Leukemia
por: Gocek, Elzbieta, et al.
Publicado: (2011)

Comparative proteomics in acute myeloid leukemia
por: Luczak, Magdalena, et al.
Publicado: (2012)

Precision therapy for acute myeloid leukemia
por: Yang, Xue, et al.
Publicado: (2018)

Novel Agents for Acute Myeloid Leukemia
por: Luppi, Mario, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_v69283hhq9g8gh1aa4j81fac48